Skip to main content
OpenTrials

Clinical trial condition

Carcinosarcoma

Explore clinical trials studying Carcinosarcoma. Study availability and eligibility vary by location and protocol.

25 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Carcinosarcoma trial results

Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

NCT05646316

Conditions
Carcinosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Doral Doral, Florida, United States
View all 60 locations
View Trial Details
Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details
Recruiting

GISAR German Interdisciplinary Sarcoma Registry

NCT04122872

Conditions
Carcinosarcoma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • HELIOS Klinikum Berlin-Buch Berlin, Germany
View all 21 locations
View Trial Details
Active, not recruiting

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

NCT03367741

Conditions
Advanced Endometrial Carcinoma, Carcinosarcoma, Endometrial Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details
Active, not recruiting

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

NCT03660826

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 761 locations
View Trial Details

Related conditions